Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in Recurrent or Persistent Endometrial Carcinoma
NCT00087100Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- May 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in endometrial adenocarcinoma, sponsored by GOG Foundation. Started May 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
endometrial adenocarcinoma
Beyond the preview
Go deeper on NCT00087100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087100.